Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

PDSB

PDS Biotechnology Corp

CIK 0001472091 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.22
↑ 0.01 (4.60%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$12.23M
P/E Ratio
-0.36
EPS
-0.74
Dividend Yield
Not covered
52W Position
2%
Beta
2.91

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-3.42
P/S
Not covered
EV/Revenue
Not covered
ROE
940.6%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 2%
$0.20$1.55

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$34.50M
Total Assets
$30.49M
Free Cash Flow
-$27.75M

Recent news